Projects per year
Personal profile
Chinese Name
Biography
Dr. DENG Zhiqiang received his Ph.D degree from Wuhan University in 2017. From 2015 to 2017, he studied at the Icahn Mount Sinai School of Medicine in the United States as a joint doctoral student. After obtaining his Ph.D degree, he received postdoctoral training at the Icahn Mount Sinai School of Medicine in the United States from 2017 to 2020. In 2021, he was engaged in research work in the University of Macau. In 2022, he joined the School of Chinese Medicine in Hong Kong Baptist University as a Research Assistant Professor.
Research Interests
Dr. Deng mainly focuses on the regulation of selective autophagy and autophagy receptors in neurodegenerative diseases (AD, PD, ALS), and the research on the regulation of autophagy activity and the neuroprotective mechanism by natural traditional Chinese medicine small molecules.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Scholars
Collaborations and top research areas from the last five years
Projects
- 2 Active
-
Investigating the mechanism of (-)Schisandrin B on the treatment of Parkinson's disease via regulating ATG16L1/NLRP3 signalling pathway
LI, M., Song, J., IYASWAMY, A. & DENG, Z.
9/10/24 → 8/10/27
Project: Research project
-
-
Corynoxine promotes TFEB/TFE3-mediated autophagy and alleviates Aβ pathology in Alzheimer’s disease models
Guan, X., Deng, Z., Liu, J., Su, C., Tong, B. C. K., Zhu, Z., Sreenivasmurthy, S. G., Kan, Y., Lu, K., Chu, C. P. K., Pi, R., Cheung, K., Iyaswamy, A., Song, J. & Li, M., May 2024, In: Acta Pharmacologica Sinica. 45, 5, p. 900–913 14 p.Research output: Contribution to journal › Journal article › peer-review
6 Citations (Scopus) -
Molecular engineering of a theranostic molecule that detects Aβ plaques, inhibits Iowa and Dutch mutation Aβ self-aggregation and promotes lysosomal biogenesis for Alzheimer's disease
Iyaswamy, A., Wang, X., Zhang, H., Vasudevan, K., Wankhar, D., Lu, K., Krishnamoorthi, S., Guan, X-J., Su, C-F., Liu, J., Kan, Y., Jaganathan, R., Deng, Z., Li, H. W., Wong, M. S. & Li, M., 21 Aug 2024, In: Journal of Materials Chemistry B. 12, 31, p. 7543-7556 14 p.Research output: Contribution to journal › Journal article › peer-review
Open AccessFile9 Downloads (Pure) -
Editorial: Autophagy in diseases—From basic to clinic
Yang, J., Ni, Z., Pi, H., Bohnert, A. & Deng, Z., 4 Jan 2023, In: Frontiers in Physiology. 13, 3 p., 1115511.Research output: Contribution to journal › Editorial
Open Access -
PPARɑ Ligand Caudatin Improves Cognitive Functions and Mitigates Alzheimer’s Disease Defects By Inducing Autophagy in Mice Models
Krishnamoorthi, S., Iyaswamy, A., Sreenivasmurthy, S. G., Thakur, A., Vasudevan, K., Kumar, G., Guan, X-J., Lu, K., Gaurav, I., Su, C-F., Zhu, Z., Liu, J., Kan, Y., Jayaraman, S., Deng, Z., Chua, K. K., Cheung, K-H., Yang, Z., Song, J-X. & Li, M., Sept 2023, In: Journal of NeuroImmune Pharmacology. 18, 3, p. 509-528 20 p.Research output: Contribution to journal › Journal article › peer-review
3 Citations (Scopus) -
Editorial: Assessing the Pharmacological Effects and Therapeutic Potential of Traditional Chinese Medicine in Neurological Disease Models: An Update
Deng, Z., Kan, Y., Li, M., Song, J. & Lu, J. H., 27 Apr 2022, In: Frontiers in Pharmacology. 13, 909153.Research output: Contribution to journal › Editorial
Open Access2 Citations (Scopus)
Activities
- 1 Editor/reviewer for publications (incl. CDCF T61 Journal Editor)
-
Frontiers in Physiology (Journal)
Zhiqiang DENG (Guest editor)
2021 → …Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)